Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Urinastatin
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Phase II
Sponsor : The First Affiliated Hospital of Guangzhou Medical University
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 09, 2016
Lead Product(s) : Urinastatin
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Phase II
Sponsor : The First Affiliated Hospital of Guangzhou Medical University
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Urinastatin
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Phase IV
Recipient : Peking Union Medical College Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Ulinastatin Treatment in Adult Patients With Sepsis and Septic Shock in China
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 06, 2016
Lead Product(s) : Urinastatin
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Phase IV
Recipient : Peking Union Medical College Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
The Study to Reevaluate the Safety and Efficacy of Human Urinary Kallikrein
Details : Undisclosed
Product Name : Undisclosed
Product Type : Enzyme
Upfront Cash : Inapplicable
September 29, 2015
Lead Product(s) : Urinastatin
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase IV
Sponsor : Shanghai Children's Medical Center | Guangzhou Women and Children's Medical Center | Guangzhou General Hospital of Guangzhou Military Command | Nanjing Children's Hospital | Children's Hospital of Fudan University
Deal Size : Inapplicable
Deal Type : Inapplicable
Ulinastatin Injection in in Pediatric Patients Undergoing Open Heart Surgery
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
August 19, 2015
Lead Product(s) : Urinastatin
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase IV
Sponsor : Shanghai Children's Medical Center | Guangzhou Women and Children's Medical Center | Guangzhou General Hospital of Guangzhou Military Command | Nanjing Children's Hospital | Children's Hospital of Fudan University
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Urinastatin
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Study Phase : Phase IV
Sponsor : Peking Union Medical College Hospital | Wuhan Union Hospital | First Clinical College of Harbin Medical University | The First Affiliated Hospital with Nanjing Medical University | West China Hospital | First Affiliated Hospital, Sun Yat-Sen University
Deal Size : Inapplicable
Deal Type : Inapplicable
Ulinastatin in Severe Acute Pancreatitis
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 28, 2010
Lead Product(s) : Urinastatin
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Highest Development Status : Phase IV
Sponsor : Peking Union Medical College Hospital | Wuhan Union Hospital | First Clinical College of Harbin Medical University | The First Affiliated Hospital with Nanjing Medical University | West China Hospital | First Affiliated Hospital, Sun Yat-Sen University
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
